计算机化风险评分用于指导疑似肝素诱导性血小板减少症的识别与诊断
该回顾性队列研究在4个月内收集所有接受肝素住院患者的HIT-CR评分,并对独立接受HIT临床诊断检测的患者进行病历回顾。仅6%高危和10%最高危患者接受了HIT检测,而317例接受独立检测的患者中67%为低危(<3分)。研究提示临床医生对多数高危患者未检测、对许多低危患者过度检测,合理应用HIT-CR评分的方法是评分<3分不推荐检测、评分4分推荐检测。
要点
- HIT-CR评分<3分者不推荐行HIT检测。
- HIT-CR评分4分者推荐行HIT检测。
- 临床对高危患者检测不足、低危患者检测过度。
核心结论
- 临床医生对多数高危HIT-CR患者未进行HIT检测,而对许多低危患者进行了不必要的检测。
- HIT-CR评分的合理临床应用为评分<3分不推荐检测、评分4分推荐检测。
研究设计与样本
- 回顾性队列研究,收集4个月内所有接受肝素住院患者的HIT-CR评分。
- 对独立接受HIT临床诊断检测的患者子集进行病历回顾以识别HIT患者。
主要发现
- 仅6%的高危HIT-CR(≥3分)患者和10%的最高危(4分)患者接受了HIT检测。
- 在317例独立接受HIT检测的患者中,67%为低危HIT-CR评分(<3分)。
关键数值与推荐
- 推荐对HIT-CR评分<3分的患者不进行检测,对评分为4分的患者进行检测。
临床怎么用
- 临床可依据HIT-CR评分分层:评分<3分者不推荐行HIT检测,评分4分者推荐行HIT检测。
- 应提高对HIT-CR评分≥3分高危患者的检测意识,避免漏诊。
- 应减少对HIT-CR评分<3分低危患者的不必要HIT检测。
局限性
- 本研究为回顾性队列研究。
- 仅对独立接受HIT临床诊断检测的患者子集进行了病历回顾。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The heparin-induced thrombocytopenia computerised risk (HIT-CR) score is designed to aid in the diagnosis of HIT. We sought to evaluate its potential clinical utility. In this retrospective cohort study, we collected HIT-CR scores on all inpatients receiving heparin over a 4-month period and performed chart reviews on the subset who independently underwent clinical diagnostic testing for HIT to identify patients with HIT. In all, 34 342 patients received heparin, 1744 had high-risk HIT-CR scores of ≥3 and 220 had the maximal risk score of 4. Only 6% of high-risk and 10% of maximal-risk patients underwent testing for HIT. Conversely, among all 317 patients who underwent independent testing for HIT, 67% had low-risk HIT-CR scores (<3). Among patients independently tested, the positive predictive value (PPV) was 6·6% [95% confidence interval (CI) 4·9-8·8%] and the negative predictive value (NPV) was 99·5% (95% CI 97·1-99·9%) at a HIT-CR score cut-off of 3, and the PPV was 22·7% (95% CI 12·7-37·4%) and NPV was 99·0% (95% CI 97·6-99·6%) at a cut-off of 4. This study suggests clinicians fail to test most high-risk patients and unnecessarily test many low-risk patients for HIT. A reasonable approach to clinical application of HIT-CR scores would be recommending no testing for patients with a score of <3 and recommend testing for patients with a score of 4.
引用
- Gallo T, Curry SC, Raschke RA, et al. Computerised risk scores to guide recognition and diagnosis in patients with possible heparin-induced thrombocytopenia. Br J Haematol. 2020. PMID: 33280095. doi:10.1111/bjh.17086
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。